• share
• favorite_border

The UC Davis Comprehensive Cancer Center received a $50,000 grant from the Safeway Foundation. The funding will allow researcher Mili Arora to study whether the spice turmeric can provide pain relief for breast cancer patients on oral anti-estrogen drugs.

• share
• favorite_border

Department of Radiology Chair Elizabeth Morris, with the UC Davis Comprehensive Cancer Center, was awarded a Susan G. Komen® grant to develop artificial intelligence models to predict breast cancer risk at a more personalized level

• share
• favorite_border

The new medical director for the UC Davis Comprehensive Cancer Center Office of Clinical Research is Dr. Edward Kim who steps into his new position e on July 1, 2021.

• share
• favorite_border

UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.

• share
• favorite_border

A new study, conducted by three UC Davis Comprehensive Cancer Center researchers, studies young adult smoking trends three years after the start of California’s law raising the sales age of tobacco to 21.

• share
• favorite_border

In one of the largest research projects of its kind, a new study published in JAMA Network Open looks at nearly 900,000 individuals and close to 2 million mammograms to come up with a new way to detect the most breast cancer cases with the fewest exams.

• share
• favorite_border

Callers to the California Smokers’ Helpline can now get an additional tool to help them quit using tobacco: nicotine patches.

• share
• favorite_border

Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don’t get it. The result, argues a team led by UC Davis Health urologists, is that the disease for many is still as deadly as it was 30 years ago.

• share
• favorite_border

Researchers at UC Davis Health and UC San Francisco have found a way to teach a computer to detect one of the hallmarks of Alzheimer’s disease

• share
• favorite_border

High-risk younger siblings of children with autism are less likely to be diagnosed with autism spectrum disorder (ASD), have significantly lower autism symptom severity, and higher cognitive scores if their mothers take maternal prenatal vitamins during their first month of pregnancy, UC Davis research has found.

• share
• favorite_border

Radiologists quickly learn to read 3D mammography more accurately than they read standard 2D mammograms, a first-of-its-kind study by a UC Davis researcher has found. Published today in Radiology, the study led by Diana Miglioretti, UC Davis dean’s professor of biostatistics, found that radiologists who interpret traditional mammograms, which are two-dimensional, required little start up time for transitioning to reading digital breast tomosynthesis (DBT), or 3D mammography, with improved screening accuracy

• share
• favorite_border

Breakthrough research demonstrating that children with autism as young as 18 months can vastly improve their language, cognition and social skills with an early intervention developed by UC Davis Professor Sally Rogers has been replicated in a major new study.

• share
• favorite_border

Dr. Meghan Miller of the UC Davis MIND Institute talks about her paper, published in JAMA Pediatrics, about the risk of younger siblings of children with autism or ADHD for either or both disorders.

• share
• favorite_border

A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors. The paradoxical findings, published today in Nature Medicine, give cancer doctors important new information when choosing drugs and other treatments for cancer patients.

• share
• favorite_border

UC Davis Comprehensive Cancer Center has received a $6.3 million grant from the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities for a 5-year study to tease out why some ethnic and racial minority groups fare worse than whites when they get cancer and to find more precise treatments to improve their chances of survival.

• share
• favorite_border

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

• share
• favorite_border

Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden (TMB) accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors. The blood test offers a much less invasive and more repeatable alternative to tissue testing. The study was published online today in Nature Medicine.

• share
• favorite_border

Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.

• share
• favorite_border

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.

• share
• favorite_border

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.

• share
• favorite_border

UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical student training app.

• share
• favorite_border

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse models.

• share
• favorite_border

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.

• share
• favorite_border

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term peripheral neuropathy, leaving little data for patients and clinicians to make informed decisions.